ProBiotix Health Plc

Director's Dealing • May 30, 2025

National Storage Mechanism | Additional information

RNS Number : 6958K

Probiotix Health PLC

30 May 2025

30 May 2025

ProBiotix Health plc

("ProBiotix Health" or the "Company" or, together with its subsidiary, the "Group")

Director/PDMR Shareholdings

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that Directors and PDMRs of the Company have acquired a total of 549,082 ordinary shares of 0.05p each in the Company ("Ordinary Shares").

Following these acquisitions, the Directors of the Company are interested in Ordinary Shares as follows:

Name	Number of Ordinary Shares acquired	Shareholding	%
Adam Reynolds	50,000	192,857	0.06
Steen Andersen	125,450	125,450	0.04
Stephen O'Hara	-	6,131,450	3.88
Marco Caspani	-	-	-
Frederik Bruhn-Petersen*	-	3,000,000	1.90

*Frederik Bruhn-Petersen is also interested in the 33,160,000 Ordinary Shares, representing 20.97% of the Company's issued share capital, held by Holdingselskabet of 29. Juni 2010 Aps.

Further information about the acquisitions of Ordinary Shares by the Directors and PDMRs is set out in the table below.

For further information, please contact:

ProBiotix Health plc	https://probiotixhealth-ir.com
Steen Andersen, Chief Executive Officer Miles Nolan, Investor Relations	[email protected]
Peterhouse Capital Limited Aquis Corporate Adviser and Broker
Mark Anwyl Duncan Vasey	Tel: 020 7220 9793

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Adam Reynolds	Steen Andersen	Mark Collingbourne	Michael Litichevski	Mads Brandt
2	Reason for the notification
a)	Position/status	Chairman	Chief Executive	Chief Finance Officer	Vice President, Sales	Head of Supply Chain
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)	Name	ProBiotix Health plc
b)	LEI	98450048683CF0388C30
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 0.05p each ISIN: GB00BLNBFR86
b)	Nature of the transactions	Acquisition of Ordinary Shares
c)	Price(s) and volume(s)	50,000 Ordinary Shares at 7.88p per share	125,450 Ordinary Shares at 7.83p per share	108,907 Ordinary Shares at 7.25p per share	75,780 Ordinary Shares at 7.25p per share	188,945 Ordinary Shares at 7.83p per share
d)	Aggregated information - Aggregated volume - Price	n/a - single transaction	n/a - single transaction	n/a - single transaction	n/a - single transaction	n/a - single transaction
e)	Date of the transactions	29 May 2025
f)	Place of the transactions	Aquis Growth Market

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXKZGZKGLKGKZZ